Table 4.
MRPRESSO testing of severe COVID-19 infection with respiratory failure and obesity and overweight.
| Exposure | Outcome | Raw | Outlier corrected | Global P | Number of outliers | Distortion P | ||
|---|---|---|---|---|---|---|---|---|
| OR (CI%) | P | OR (CI%) | P | |||||
| ebi-a-GCST001475 | Severe COVID-19 infection with respiratory failure (analysis I) | 1.12 (0.94–1.33) | .23 | NA | NA | .53 | NA | NA |
| finn-b-E4_OBESITY | 1.16 (0.96–1.42) | .14 | NA | NA | .23 | NA | NA | |
| finn-b-E4_OBESITY_HYPER | 1.17 (0.96–1.44) | .14 | NA | NA | .18 | NA | NA | |
| finn-b-E4_OBESITYCAL | 1.08 (0.89–1.31) | .44 | NA | NA | .60 | NA | NA | |
| finn-b-E4_OBESITYDRUG | 1.02 (0.99–1.05) | .28 | NA | NA | .88 | NA | NA | |
| finn-b-E4_OBESITYXTRMALV | 1.01 (0.94–1.09) | .82 | NA | NA | .46 | NA | NA | |
| finn-b-I9_HEARTFAIL_AND_OVERWEIGHT | 0.76 (0.56–1.03) | .09 | NA | NA | .71 | NA | NA | |
| ieu-a-1096 | 1.12 (0.94–1.33) | .23 | NA | NA | .49 | NA | NA | |
| ieu-a-90 | 1.07 (0.92–1.26) | .38 | NA | NA | .93 | NA | NA | |
| ieu-a-91 | 1.06 (0.92–1.23) | .41 | NA | NA | .49 | NA | NA | |
| ieu-a-92 | 0.95 (0.83–1.08) | .45 | NA | NA | .69 | NA | NA | |
| ieu-a-93 | 0.99 (0.75–1.29) | .92 | NA | NA | .80 | NA | NA | |